Cargando…
Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats
The blood-brain barrier (BBB) is the major clinical obstacle in the chemotherapeutic management of brain glioma. Here we synthesized a pH-sensitive dual-targeting doxorubicin (DOX) carrier to compromise tumor endothelial cells, enhance BBB transportation, and improve drug accumulation in glioma cell...
Autores principales: | Hu, Jiangang, Zhang, Xiang, Wen, Zuhuang, Tan, Ying, Huang, Ning, Cheng, Si, Zheng, Huzhi, Cheng, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342007/ https://www.ncbi.nlm.nih.gov/pubmed/27655664 http://dx.doi.org/10.18632/oncotarget.12047 |
Ejemplares similares
-
A preliminary study on the interaction between Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles and vascular epithelial cells
por: Liu, Chunxi, et al.
Publicado: (2017) -
Monocyte adhesion to atherosclerotic matrix proteins is enhanced by Asn-Gly-Arg deamidation
por: Dutta, Bamaprasad, et al.
Publicado: (2017) -
Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy
por: Zhu, Liqin, et al.
Publicado: (2020) -
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
por: Seidi, Khaled, et al.
Publicado: (2018) -
Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer
por: Shi, Jinjin, et al.
Publicado: (2013)